Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Rotarix launched in U.K.

June 1, 2006

ImmuFact IMP-321 completes phase I studies

June 1, 2006

Astellas files for Japanese approval of once-daily tacrolimus

June 1, 2006

Sphingosine 1-phosphate S1P1 receptor agonists emerge from Merck R&D

May 31, 2006

Apilimod mesylate studied for rheumatoid arthritis and CVID in two new studies

May 26, 2006

Debiopharm and TcLand sign inlicensing option agreement for sc28AT

May 24, 2006

Virosome Biologicals' intranasal influenza vaccine successfully completes phase I trials

May 17, 2006

Chelsea Therapeutics and Active Biotech sign codevelopment agreement

May 12, 2006

Hollis-Eden plans phase I for Neumune in hospital-acquired infections

May 8, 2006

RotaTeq recommended for approval in Europe

May 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...